Detalles de la búsqueda
1.
Postoperative Outcome of Patients Who Underwent Total Joint Replacement During the Tanezumab Phase 3 Osteoarthritis Development Program: A 24-Week Observational Study.
Surg Technol Int
; 38: 467-477, 2021 05 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34043229
2.
Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period.
Ann Rheum Dis
; 79(6): 800-810, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32234715
3.
Response to: 'Use of tanezumab for patients with hip and knee osteoarthritis with reference to a randomised clinical trial by Berenbaum and colleagues' by Riddle and Perera.
Ann Rheum Dis
; 81(4): e66, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32424029
4.
Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3).
Am J Ophthalmol
; 263: 23-34, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38395329
5.
Subcutaneous tanezumab for osteoarthritis: Is the early improvement in pain and function meaningful and sustained?
Eur J Pain
; 25(7): 1525-1539, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33728717
Resultados
1 -
5
de 5
1
Próxima >
>>